ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Turnstone Biologics Corporation

Turnstone Biologics Corporation (TSBX)

0.3747
0.0265
(7.61%)
0.3659
-0.0088
(-2.35%)

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
0.3659
Bid
0.366
Ask
0.3748
Volume
82,435
0.3359 Day's Range 0.3747
0.29 52 Week Range 3.05
Market Cap
Previous Close
0.3482
Open
0.3392
Last Trade
1
@
0.366
Last Trade Time
Financial Volume
$ 30,450
VWAP
0.369387
Average Volume (3m)
276,099
Shares Outstanding
23,140,349
Dividend Yield
-
PE Ratio
-0.12
Earnings Per Share (EPS)
-3.06
Revenue
-
Net Profit
-70.84M

About Turnstone Biologics Corporation

Turnstone Biologics Corp. is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The Company is focused on developing tumor infiltrating lymphocytes (TIL) therapies designed to drive clinical benefit and curative outcomes across mu... Turnstone Biologics Corp. is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The Company is focused on developing tumor infiltrating lymphocytes (TIL) therapies designed to drive clinical benefit and curative outcomes across multiple solid tumors. Its selected TIL approach focuses on selecting and expanding potent tumor-reactive T cells to overcome the limitations of bulk TILs. Its pipeline includes TIDAL-01 and TIDAL-02. Its lead selected TIL product candidate, TIDAL-01, utilizes an unbiased identification and functional screening process to isolate and selectively expand the breadth of tumor-reactive TILs from the patient's tumor. Its next selected TIL program, TIDAL-02, is being designed to encompass a streamlined manufacturing process for tumor-reactive T cells and additional modifications to enhance TIL quality and function. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
La Jolla, California, USA
Founded
-
Turnstone Biologics Corporation is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker TSBX. The last closing price for Turnstone Biologics was $0.35. Over the last year, Turnstone Biologics shares have traded in a share price range of $ 0.29 to $ 3.05.

Turnstone Biologics currently has 23,140,349 shares outstanding. The market capitalization of Turnstone Biologics is $8.06 million. Turnstone Biologics has a price to earnings ratio (PE ratio) of -0.12.

TSBX Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0041-1.108108108110.370.37650.334902400.35652189CS
40.02597.617647058820.340.380.29036394350.34672475CS
12-0.0304-7.67095634620.39630.41990.292760990.34924021CS
26-0.112449-23.50773180250.4783490.62320.292381310.39357078CS
52-2.3241-86.39776951672.693.050.292530250.67373025CS
156-11.0341-96.790350877211.413.20.291915761.64190804CS
260-11.0341-96.790350877211.413.20.291915761.64190804CS

TSBX - Frequently Asked Questions (FAQ)

What is the current Turnstone Biologics share price?
The current share price of Turnstone Biologics is $ 0.3659
How many Turnstone Biologics shares are in issue?
Turnstone Biologics has 23,140,349 shares in issue
What is the market cap of Turnstone Biologics?
The market capitalisation of Turnstone Biologics is USD 8.06M
What is the 1 year trading range for Turnstone Biologics share price?
Turnstone Biologics has traded in the range of $ 0.29 to $ 3.05 during the past year
What is the PE ratio of Turnstone Biologics?
The price to earnings ratio of Turnstone Biologics is -0.12
What is the reporting currency for Turnstone Biologics?
Turnstone Biologics reports financial results in USD
What is the latest annual profit for Turnstone Biologics?
The latest annual profit of Turnstone Biologics is USD -70.84M
What is the registered address of Turnstone Biologics?
The registered address for Turnstone Biologics is 9310 ATHENA CIRCLE, SUITE 300, LA JOLLA, CALIFORNIA, 92037
Which industry sector does Turnstone Biologics operate in?
Turnstone Biologics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CEROCERo Therapeutics Holdings Inc
$ 19.92
(190.04%)
57.35M
ACXPAcurx Pharmaceuticals Inc
$ 0.8149
(165.35%)
337.39M
EYENEyenovia Inc
$ 6.96
(134.34%)
29.94M
RBNERobin Energy Ltd
$ 10.60
(92.03%)
45.44M
RELIReliance Global Group Inc
$ 2.20
(86.44%)
19.29M
SDSTStardust Power Inc
$ 0.186
(-52.10%)
39.42M
SHOTWSafety Shot Inc
$ 0.0161
(-45.97%)
12.35k
RUNSunrun Inc
$ 5.78
(-40.04%)
120.05M
SEDGSolarEdge Technologies Inc
$ 15.94
(-33.53%)
33.14M
GOVXGeoVax Labs Inc
$ 0.8924
(-32.39%)
2.64M
PCSAProcessa Pharmaceuticals Inc
$ 0.2632
(16.93%)
575.5M
GNLNGreenlane Holdings Inc
$ 0.0104
(-16.13%)
392.94M
HCTIHealthcare Triangle Inc
$ 0.022
(-16.67%)
356.57M
ACXPAcurx Pharmaceuticals Inc
$ 0.8149
(165.35%)
337.45M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 11.9373
(-7.75%)
143.55M

TSBX Discussion

View Posts
jondoeuk jondoeuk 8 months ago
60% RIF (cash into 2026) https://www.oncologypipeline.com/apexonco/no-easy-ride-turnstone
👍️0
Stock Shakers Stock Shakers 10 months ago
https://www.tipranks.com/stocks/tsbx/forecast
👍️0
Monksdream Monksdream 10 months ago
TSBX new 52+week low
👍️0
jondoeuk jondoeuk 10 months ago
I assume (rightly or wrongly) it is down as they were supposed to have shared data on ~20-30 patients. There was also no conference call and they cut two indications (I agree with melanoma). Data shows promise, but you have to show the market more than that.

https://finance.yahoo.com/news/turnstone-biologics-corp-reports-positive-200100662.html
👍️0
Monksdream Monksdream 11 months ago
TSBX under $3
👍️0
Monksdream Monksdream 11 months ago
TSBX under $3
👍️0
stock1ace1 stock1ace1 12 months ago
$3.02
👍️0
stock1ace1 stock1ace1 12 months ago
$2.94 buys coming in
👍️0
stock1ace1 stock1ace1 12 months ago
Tsbx -> We remain on track and plan to provide a TIDAL-01 clinical update mid-year in connection with our next quarterly financial results.”
👍️0
stock1ace1 stock1ace1 12 months ago
$3.00s (200ma break) #Bullish
👍️0
stock1ace1 stock1ace1 12 months ago
Tsbx $2.99 Pending data look at chart -> https://schrts.co/JiDydKgr
👍️0
Monksdream Monksdream 1 year ago
TSBX under $3
👍️0
jondoeuk jondoeuk 1 year ago
CEO saying data in July-August.
👍️0
Monksdream Monksdream 1 year ago
TSBX under $3
👍️0
Laster Laster 1 year ago
Nice biotech company. Looks like it wants to break out past $3.50.
I think it has a lot more to run,
JMO.
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
TSBX....here we go...monster bio
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
TSBX...MONSTER BIO BEAST IS READY TO BLOW UP
👍️0
jondoeuk jondoeuk 1 year ago
What was?
👍️0
Awl416 Awl416 2 years ago
That was quick
👍️0
jondoeuk jondoeuk 2 years ago
New #JITC article: Neoantigen-specific CD4+ tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients https://t.co/jORw8004JP @JohnEMullinaxMD pic.twitter.com/a7RR2K5MrQ— Journal for ImmunoTherapy of Cancer (@jitcancer) October 6, 2023
👍️0
jondoeuk jondoeuk 2 years ago
Upcoming https://finance.yahoo.com/news/turnstone-biologics-present-preclinical-data-100000133.html
👍️0

Your Recent History

Delayed Upgrade Clock